Target market RheoSense serves biotechnology, pharmaceutical, and emerging protein therapeutics sectors with viscometry solutions, presenting a direct sales opportunity to large R&D labs, CROs, and pharma manufacturers seeking small sample volume measurements and high accuracy.

Recent launches New microVISC PRO and HTScreen mode with VROC initium one plus indicate expanded product capabilities and safety certifications, signaling upsell and cross-sell opportunities to existing customers and channels seeking advanced instrumentation and compliance-ready devices.

Growth signals Global adoption by Fortune Global 500 companies and top research universities suggests strong reference potential, enabling targeted outreach to procurement and lab managers at large organizations for pilots, trials, and volume license deals.

Productivity focus Small sample volume, ease of use, and MEMS/microfluidics-driven accuracy position RheoSense as a cost-effective, high-efficiency viscometry option for high-throughput labs, enabling ROI-focused propositions for workflow optimization and lab consolidation.

Expansion readiness Recent software and hardware updates, along with a Chip Cleaning Station and ongoing product enhancements, create opportunities for bundled offerings, maintenance/service contracts, and training packages to improve contract value and customer retention.